Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine

Journal of Applied Toxicology

Volumn 22, Issue 3, 2002, Pages 141-148

  Scott Duncan, E J ^a   Brown, April ^b   Lundy, Paul ^a   Sawyer, Thomas W ^a   Hamilton, Murray ^a   Hill, Ira ^b   Conley, John D ^b  

^a Box 4000 Station Main   (Canada)

^b Kinchyle Enterprises Inc   (Canada)

Author keywords

Absorption; Chemical warfare agents; Domestic swine model; Methyl salicylate; Percutaneous absorption; Protective clothing; VX

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CHOLINESTERASE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; ORGANOPHOSPHATE; SALICYLIC ACID; SALICYLIC ACID METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CHOLINESTERASE BLOOD LEVEL; CHOLINESTERASE INHIBITION; CLINICAL FEATURE; CONTAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; DOMESTIC ANIMAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG HYDROLYSIS; DRUG METABOLISM; EAR; ENZYME ACTIVITY; INGUINAL REGION; INTOXICATION; MEDICAL ASSESSMENT; NONHUMAN; PERINEUM; PRIORITY JOURNAL; PROGNOSIS; PROTECTIVE CLOTHING; SKIN ABSORPTION; SURVIVAL; SWINE; TOXICITY TESTING;

ABDOMEN; ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASES; EAR; INGUINAL CANAL; MALE; MODELS, ANIMAL; ORGANOTHIOPHOSPHORUS COMPOUNDS; PERINEUM; SALICYLATES; SKIN; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0036268502     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.838     Document Type: Article

References (59)

1. Pharmokinetic factors affecting epidermal penetration and percutaneous absorption
2. Methods for in vitro percutaneous absorption studies. I: Comparison with in vivo results
3. Percutaneous absorption of nitroaromatic compounds: In vivo and in vitro studies in the human and monkey
4. Comparison of the in vivo and in vitro percutaneous absorption of a lipophilic molecule (Cypermethrin, a pyrrethroid insecticide)
5. Skin permeability theory in relation to measurements of percutaneous absorption in toxicology
6. Skin permeability in vivo: Comparison in rat, rabbit pig and man
7. Methods for in vitro percutaneous absorption studies. II: Animal models for human skin
8. Development of an in vitro model for determining the fate of chemicals applied to skin
9. In vitro percutaneous absorption: Pig epidermal membrane as a model for human skin
10. Comparisons of in vitro nitroglycerin (TNG) flux across Yutacan pig, hairless mouse and human skins
11. Pig ear skin as an in vitro model for human skin permeability
12. Percutaneous absorption in the rhesus monkey compared to man
13. Dermal absorption of the phenoxy herbicides 2,4-D amine, 2,4-D isoctyl and 2,4,5-T in rabbits, rats, rhesus monkeys and humans: A cross species comparison
14. The skin of domestic mammals as a model for the human skin with special reference to the domestic pig
15. The skin of the domestic pig
16. Ultrastructural evaluation of the porcine integument
17. Ultrastructure of the integument of the domestic pig (Sus scrofa) from 1 through 14 weeks of age
18. Structural and histochemical aspects of epidermis development of fetal porcine skin
19. Healing of full thickness cutaneous wound in the pig
20. Immunohistochemistry of porcine skin
21. Vascular supply of the skin and hair in swine
22. Elastic fibre arrangement in the skin of the pig
23. Collagen fibre arrangement in the skin of the pig
24. Comparative anatomy and physiology of the skin
25. Comparison turnover time of keratinous protein fractions in swine and human epidermis
26. The pig as a model for cutaneous pharmacology and toxicology research
27. Permeability of the skin
28. 14C cortisol in man
29. Regional variation in percutaneous penetration in man: Pesticides
30. Topical bioavailability of methyl salicylate
31. The Canadian vapour protection systems test: A novel methodology to assess the protection capability of CB protective ensembles
32. Is there tissue penetration after application of topical salicylate formulations?
33. On the metabolism and toxicity of methyl salicylate
34. Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in plasma
35. Salicylate metabolism in man
36. Clinical pharmacology of salicylates
37. Absorption, metabolism, and excretion of salicylates
38. A kinetic study of the elimination of salicylate in man
39. Biotransformation of salicylic acid to its acyl and phenolic glucuronides in man
40. Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis
41. Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid and gentisic acid in urine
42. Analysis of salicylic acid in serum by high-performance liquid chromatography
43. Correlation of plateau salicylate level with rate of salicylate metabolism
44. Pharmokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man
45. The elimination of salicylic acid in man: Serum concentrations and urinary excretion rates
46. Metabolism of salicylate during chronic asprin therapy
47. Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis
48. Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous asprin in a porcine model
49. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations
50. Toxicity of organophosphate chemical warfare agents GA, GB and VX; implications for public protection
51. Species differences in biotransformation and excretion of salicylate
52. Serum concentrations of serum salicylic acid following topically applied salicylate derivatives
53. Effect of exercise and heat exposure on percutaneous absorption of methyl salicylate
54. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies
55. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats
56. Percutaneous absorption of salicylic acid